Results 241 to 250 of about 1,437,159 (301)
Trends in the age-standardized prevalence of neurodevelopmental disorders in South America, 1990-2023. [PDF]
Lopez-Espejo M.
europepmc +1 more source
ABSTRACT Introduction GRIA2 encodes the GluA2 ionotropic α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid (AMPA) receptor subunit. Pathogenic GRIA2 variants cause epilepsy, developmental delay, and neurobehavioral disorders. Characterizations of clinical features, including seizure types and their treatments, in patients with GRIA2‐related ...
Sai Srihitha Dommata +9 more
wiley +1 more source
Transition clinic for neurodevelopmental disorders: preliminary findings from an interdisciplinary model for adolescence to adulthood. [PDF]
Güler HA +6 more
europepmc +1 more source
Opsoclonus in Pediatric Patients: Differential Diagnosis and a Practical Approach to Evaluation
ABSTRACT Opsoclonus is an ocular dyskinesia characterized by involuntary, arrhythmic, multidirectional saccades. In pediatrics, opsoclonus is most commonly attributed to the rare neuroinflammatory disorder opsoclonus‐myoclonus‐ataxia syndrome (OMAS), typically considered a paraneoplastic syndrome associated with neural crest tumors. However, opsoclonus
Aubrey C. Reed +5 more
wiley +1 more source
Metabolomic alterations in cord blood improve the prediction of childhood-onset neurodevelopmental disorders. [PDF]
Girchenko P +7 more
europepmc +1 more source
Pregnancy‐associated breast cancer (PrBC) presents therapeutic challenges. Understanding maternal–fetal safety of systemic anticancer therapies is critical. We performed a case/non‐case disproportionality analysis using the WHO global pharmacovigilance database up to January 2024, to evaluate maternal–fetal outcomes associated with breast cancer (BC ...
Rayan Kabirian +12 more
wiley +1 more source
Maternal-fetal immune conflict contributes to male-specific impairments in a mouse model of neurodevelopmental disorders. [PDF]
Sanchez-Martin I +8 more
europepmc +1 more source

